Is the practice of medicine impeding medical innovation?
At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me to re-examine the question of whether the practice of medicine is capable of keeping pace with medical innovation.
As mentioned in a previous post, the majority of patients receiving the personalized medicine drug Herceptin had not [...]


04. Nov, 2009 





































